BDSI remains committed to the chronic pain community during the COVID-19 pandemic. For more
information on access to our products, please call our customer service line at 1-800-469-0261.

Stay Connected

Stay up to date on the latest news and innovations from BDSI.

Asterisks denote required fields

BDSI values your privacy and will use means compliant with applicable laws to secure any personally identifiable information you provide to us. We, and parties acting on our behalf, will only use such information to send you requested materials and other helpful updates. By providing us with your information, you are hereby consenting to allow us and parties acting on our behalf to collect, store, and use the information for this purpose. At any time, if you wish to stop receiving any materials and updates or want to remove the provided information from our database, contact us at 919.582.9050.

Recent BDSI News

September 11, 2020

New Scientific Information Further Highlights Differentiated Clinical Profile of BELBUCA® (buprenorphine buccal film) RALEIGH, N.C. , Sept. 11, 2020 (GLOBE NEWSWIRE) -- BioDelivery Sciences International , Inc. (NASDAQ: BDSI), a rapidly growing specialty pharmaceutical company dedicated to patients

Read more
September 3, 2020

RALEIGH, N.C. , Sept. 03, 2020 (GLOBE NEWSWIRE) -- BioDelivery Sciences International , Inc. (NASDAQ: BDSI), a rapidly growing specialty pharmaceutical company dedicated to patients living with serious and complex chronic conditions, today announced that Jeffrey Bailey , Interim Chief Executive

Read more
August 5, 2020

Second Quarter Total Company Net Revenue Increased 23% versus Prior Year to $36.6 Million Second Quarter BELBUCA® Net Sales Increased 34% versus Prior Year to $32.3 Million BELBUCA and Symproic® Each Reach All Time High TRx Volume and Market Share Conference Call and Webcast Scheduled for 8:30 AM

Read more
More news

Upcoming Events

There are no events to display

Stay Connected

Stay up to date on the latest news

Get started now
October 19, 2020BDSI $3.52/ - 0%
Data provided by Nasdaq. Minimum 15 minutes delayed.